406 related articles for article (PubMed ID: 27578257)
1. Aging increases the susceptibility of hepatic inflammation, liver fibrosis and aging in response to high-fat diet in mice.
Kim IH; Xu J; Liu X; Koyama Y; Ma HY; Diggle K; You YH; Schilling JM; Jeste D; Sharma K; Brenner DA; Kisseleva T
Age (Dordr); 2016 Aug; 38(4):291-302. PubMed ID: 27578257
[TBL] [Abstract][Full Text] [Related]
2. Differential Immunometabolic Phenotype in Th1 and Th2 Dominant Mouse Strains in Response to High-Fat Feeding.
Jovicic N; Jeftic I; Jovanovic I; Radosavljevic G; Arsenijevic N; Lukic ML; Pejnovic N
PLoS One; 2015; 10(7):e0134089. PubMed ID: 26218873
[TBL] [Abstract][Full Text] [Related]
3. Effects of indoleamine 2,3-dioxygenase deficiency on high-fat diet-induced hepatic inflammation.
Nagano J; Shimizu M; Hara T; Shirakami Y; Kochi T; Nakamura N; Ohtaki H; Ito H; Tanaka T; Tsurumi H; Saito K; Seishima M; Moriwaki H
PLoS One; 2013; 8(9):e73404. PubMed ID: 24039933
[TBL] [Abstract][Full Text] [Related]
4. A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice.
Kubota N; Kado S; Kano M; Masuoka N; Nagata Y; Kobayashi T; Miyazaki K; Ishikawa F
Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):422-30. PubMed ID: 23611112
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet-induced obesity.
Wang B; Sun J; Li X; Zhou Q; Bai J; Shi Y; Le G
Nutr Res; 2013 Nov; 33(11):971-81. PubMed ID: 24176237
[TBL] [Abstract][Full Text] [Related]
6. Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.
Luo X; Li H; Ma L; Zhou J; Guo X; Woo SL; Pei Y; Knight LR; Deveau M; Chen Y; Qian X; Xiao X; Li Q; Chen X; Huo Y; McDaniel K; Francis H; Glaser S; Meng F; Alpini G; Wu C
Gastroenterology; 2018 Dec; 155(6):1971-1984.e4. PubMed ID: 30213555
[TBL] [Abstract][Full Text] [Related]
7. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.
Barreyro FJ; Holod S; Finocchietto PV; Camino AM; Aquino JB; Avagnina A; Carreras MC; Poderoso JJ; Gores GJ
Liver Int; 2015 Mar; 35(3):953-66. PubMed ID: 24750664
[TBL] [Abstract][Full Text] [Related]
8. High-fat diet induced obesity primes inflammation in adipose tissue prior to liver in C57BL/6j mice.
van der Heijden RA; Sheedfar F; Morrison MC; Hommelberg PP; Kor D; Kloosterhuis NJ; Gruben N; Youssef SA; de Bruin A; Hofker MH; Kleemann R; Koonen DP; Heeringa P
Aging (Albany NY); 2015 Apr; 7(4):256-68. PubMed ID: 25979814
[TBL] [Abstract][Full Text] [Related]
9. Combination effects of airborne particulate matter exposure and high-fat diet on hepatic fibrosis through regulating the ROS-endoplasmic reticulum stress-TGFβ/SMADs axis in mice.
Ding S; Yu L; An B; Zhang G; Yu P; Wang Z
Chemosphere; 2018 May; 199():538-545. PubMed ID: 29455124
[TBL] [Abstract][Full Text] [Related]
10. [Effect of inflammatory stress on hepatic cholesterol accumulation and hepatic fibrosis in C57BL/6J mice].
Liu Y; Zuo GQ; Zhao L; Chen YX; Ruan XZ; Zuo DY
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):116-20. PubMed ID: 23663883
[TBL] [Abstract][Full Text] [Related]
11. Exercise training attenuates hepatic inflammation, fibrosis and macrophage infiltration during diet induced-obesity in mice.
Kawanishi N; Yano H; Mizokami T; Takahashi M; Oyanagi E; Suzuki K
Brain Behav Immun; 2012 Aug; 26(6):931-41. PubMed ID: 22554494
[TBL] [Abstract][Full Text] [Related]
12. Gut microbial metabolite TMAO contributes to renal dysfunction in a mouse model of diet-induced obesity.
Sun G; Yin Z; Liu N; Bian X; Yu R; Su X; Zhang B; Wang Y
Biochem Biophys Res Commun; 2017 Nov; 493(2):964-970. PubMed ID: 28942145
[TBL] [Abstract][Full Text] [Related]
13. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
14. Strain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype.
Farrell GC; Mridha AR; Yeh MM; Arsov T; Van Rooyen DM; Brooling J; Nguyen T; Heydet D; Delghingaro-Augusto V; Nolan CJ; Shackel NA; McLennan SV; Teoh NC; Larter CZ
Liver Int; 2014 Aug; 34(7):1084-93. PubMed ID: 24107103
[TBL] [Abstract][Full Text] [Related]
15. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction.
Cheng C; Tan J; Qian W; Zhang L; Hou X
Life Sci; 2018 Sep; 209():157-166. PubMed ID: 30096384
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
[TBL] [Abstract][Full Text] [Related]
17. Silymarin alleviates hepatic oxidative stress and protects against metabolic disorders in high-fat diet-fed mice.
Feng B; Meng R; Huang B; Shen S; Bi Y; Zhu D
Free Radic Res; 2016; 50(3):314-27. PubMed ID: 26758315
[TBL] [Abstract][Full Text] [Related]
18. Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model.
Kim S; Sohn I; Ahn JI; Lee KH; Lee YS; Lee YS
Gene; 2004 Sep; 340(1):99-109. PubMed ID: 15556298
[TBL] [Abstract][Full Text] [Related]
19. Secreted modular calcium-binding protein 2 promotes high fat diet (HFD)-induced hepatic steatosis through enhancing lipid deposition, fibrosis and inflammation via targeting TGF-β1.
Yuting Y; Lifeng F; Qiwei H
Biochem Biophys Res Commun; 2019 Jan; 509(1):48-55. PubMed ID: 30581002
[TBL] [Abstract][Full Text] [Related]
20. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
